CD4 and lung adenocarcinoma: Notch2 mRNA expression was comparable in peripheral CD4+ T cells between NC and lung adenocarcinoma patients (P=0.148, Figure 1E) and in BALF CD4+ T cells between nontumor and tumor sites (P=0.288, Figure 1F).